Cancer-associated alteration in fatty acid binding to albumin studied by spin-label electron spin resonance

Cancer Investigation

Volumn 25, Issue 6, 2007, Pages 378-383

  Gurachevsky, Andrey ^a   Muravskaya, Ekaterina ^b   Gurachevskaya, Tatjana ^a   Smirnova, Lena ^c   Muravsky, Vladimir ^a  

^a MedInnovation GmbH   (Germany)

^b International Sakharov Environmental University   (Belarus)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cancer; Electron spin resonance; Fatty acid; Neural networks; Serum albumin; Spin probe

Indexed keywords

ALBUMIN; FATTY ACID; HUMAN SERUM ALBUMIN; TUMOR MARKER;

ALLOSTERISM; ARTICLE; ARTIFICIAL NEURAL NETWORK; BINDING AFFINITY; BINDING SITE; BLOOD SAMPLING; CANCER PATIENT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DATA ANALYSIS; DIAGNOSTIC ACCURACY; ELECTRON SPIN RESONANCE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN MODIFICATION; PROTEIN PROCESSING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BINDING SITES; CYCLIC N-OXIDES; ELECTRON SPIN RESONANCE SPECTROSCOPY; FATTY ACIDS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; SERUM ALBUMIN; SPIN LABELS;

EID: 34648828514     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900701407947     Document Type: Article

References (25)

1. Johann, D.J., Jr.; McGuigan, M.D.; Patel, A.R.; Tomov, S.; Ross, S.; et al. Clinical proteomics and biomarker discovery. Ann. N.Y. Acad. Sci. 2004, 1022, 295-305.
2. Mehta, A.I.; Ross, S.; Lowenthal, M.S.; Fusaro, V.; Fishman, D.A.; Petricoin, E.F., III; Liotta, L.A. Biomarker amplification by serum carrier protein binding. Dis. Markers 2003, 19 (1), 1-10.
3. Liotta, L.A.; Ferrari, M.; Petricoin, E. Clinical proteomics: written in blood. Nature 2003, 425 (6961), 905.
4. Laursen, I.; Briand, P.; Lykkesfeldt, A.E. Serum albumin as a modulator on growth of the human breast cancer cell line, MCF-7. Anticancer Res. 1990, 10 (2A), 343-351.
5. Ascenzi, P.; Bocedi, A.; Bolli, A.; Fasano, M.; Notari, S.; Polticelli, F. Allosteric modulation of monomeric proteins. Biochem. Educ. 2005, 33 (3), 169-176.
6. Chen, J.; Hage, D.S. Quantitative analysis of allosteric drug-protein binding by biointeraction chromatography. Nat. Biotechnol. 2004, 22 (11), 1445-1448.
7. Janssen, L.H.; Van Wilgenburg, M.T.; Wilting, J. Human serum albumin as an allosteric two-state protein. Evidence from effects of calcium and warfarin on proton binding behaviour. Biochim. Biophys. Acta 1981, 669 (2), 244-250.
8. Wainer, I.W. Finding time for allosteric interactions. Nat. Biotechnol. 2004, 22 (11), 1376-1377.
9. Berliner, L.J. Spin Labeling: Theory and Applications; Academic Press: New York; 1976.
10. Ge, M.T.; Rananavare, S.B.; Freed, J.H. ESR studies of stearic acid binding to bovine serum albumin. Biochim. Biophys. Acta 1990, 1036 (3), 228-236.
11. Livshits, V.A.; Marsh, D. Fatty acid binding sites of serum albumin probed by non-linear spin-label EPR. Biochim. Biophys. Acta 2000, 1466 (1-2), 350-360.
12. Matthes, G.; Seibt, G.; Muravsky, V.; Hersmann, G.; Dornheim, G. Albumin transport analysis of different collected and processed plasma products by electron spin resonance spectroscopy. Transfus. Apher. Sci. 2002, 27 (2), 129-135.
13. Afanas'eva, A.N.; Evtushenko, V.A. Conformation changes in albumin molecule as a marker of dissemination of the tumor process. Bull. Exp. Biol. Med. 2004, 138 (2), 177-178.
14. Lowenthal, M.S.; Mehta, A.I.; Frogale, K.; Bandle, R.W.; Araujo, R.P.; Hood, B.L.; Veenstra, T.D.; Conrads, T.P.; Goldsmith, P.; Fishman, D.; Petricoin, E.F., III; Liotta, L.A. Analysis of albumin-associated peptides and proteins from ovarian cancer patients. Clin. Chem. 2005, 51 (10), 1933-1945.
15. Muravskaya, E.V.; Lapko, A.G.; Muravskii, V.A. Modification of transport function of plasma albumin during atherosclerosis and diabetes mellitus. Bull. Exp. Biol. Med. 2003, 135 (5), 433-435.
16. Tolkacheva, N.V.; Levachev, M.M.; Kulakova, S.N.; Grishkovets, V.I.; Klishevich, I.B. A structural-functional assessment of serum albumin in cancerous diseases. Vopr. Onkol. 1991, 37(3), 293-297.
17. Graner, M.W.; Likhacheva, A.; Davis, J.; Raymond, A.; Brandenberger, J.; Romanoski, A.; Thompson, S.; Akporiaye, E.; Katsanis, E. Cargo from tumor-expressed albumin inhibits T-cell activation and responses. Cancer Res. 2004, 64 (21), 8085-8092.
18. Thumser, A.E.; Voysey, J.E.; Wilton, D.C. The binding of lysophospholipids to rat liver fatty acid-binding protein and albumin. Biochem. J. 1994, 301 (3), 801-806.
19. Muravsky, V.; Gurachevsky, A.; Gurachevskaya, T.; Matthes, G.; Schnurr, K.; Smirnova, L. Routine laboratory test for determination of albumin transport characteristics and cancer diagnostics. Sakharov readings 2004: environmental problems of the XXI century; Vol 1. Trioleta: Minsk, 2004.
20. Yousefizadeh, H.; Zilouchian, A. Neural Network Architectures. In: Intelligent control systems using soft computing methodologies; CRC Press, Boca Raton, FL, 2001.
21. Astion, M.L.; Wilding, P. Application of neural networks to the interpretation of laboratory data in cancer diagnosis. Clin. Chem. 1992, 38 (1), 34-38.
22. Poon, T.C.; Chan, A.T.; Zee, B.; Ho, S.K.; Mok, T.S.; Leung, T.W.; Johnson, P.J. Application of classification tree and neural network algorithms to the identification of serological liver marker profiles for the diagnosis of hepatocellular carcinoma. Oncology 2001, 61 (4), 275-283.
23. Peters, T. All about albumin: biochemistry, genetics, and medical applications; Academic Press, San Diego; 1996.
24. Curry, S.; Mandelkow, H.; Brick, P.; Franks, N. Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Nat. Struct. Biol. 1998, 5 (9), 827-835.
25. Mashevsky, A.; Muravsky, V.; Milutin, A.; Javrid, E.; Korotkevich, E.; Prokchorova, V.; et.al. Dynamics of ESR spectra of the spin labeled blood serum under neoplastic process. Ukr. Radiol. Zh. 1994, 4, 268-270.